BIOVIE INC.
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
BIVI | NDAQ
Overview
Corporate Details
- ISIN(s):
 - N/A
 - LEI:
 - Country:
 - United States of America
 - Address:
 - 680 W NYE LANE, 89703 CARSON CITY
 - Website:
 - https://www.bioviepharma.com/
 - Sector:
 - Manufacturing
 - Industry:
 - Manufacture of pharmaceuticals, medicinal chemical and botanical products
 
Description
BioVie Inc. is a clinical-stage biopharmaceutical company developing innovative drug therapies for chronic debilitating conditions, with a primary focus on neurological, neurodegenerative, and advanced liver diseases. The company's scientific approach posits that inflammation is a central factor in the progression of these disorders. Its lead therapeutic candidate, bezisterim, is a novel molecule being studied for the treatment of Alzheimer's and Parkinson's disease, aiming to modulate inflammation and enhance brain energy transfer. BioVie is also developing treatments for ascites, a common and life-threatening complication of advanced liver cirrhosis. The company's research incorporates advanced science, including the study of epigenetic mechanisms like DNA methylation to regulate gene expression.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BIOVIE INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BIOVIE INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BIOVIE INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||